常规杂质对照品,用于杂质谱定位、强制降解产物的峰归属以及外标法定量;建议同时确认主峰与相邻杂质峰的分离度 ≥1.5。A conventional impurity standard for impurity profiling, peak assignment of forced-degradation products and external-standard quantification; confirm resolution ≥1.5 between the main peak and adjacent impurities.
鲁拉西酮杂质35Lurasidone Impurity 35CAS 号No. 1373868-14-4
Lurasidone Impurity 35
| CAS 号CAS No. | 1373868-14-4 |
| 分子式Molecular Formula | C28H34N4O3S |
| 分子量Molecular Weight | 506.7 g/mol |
| 分类Category | 药物杂质对照品 / Impurity Reference StandardsImpurity Reference Standards |
| 纯度Purity | >95% |
| 库存状态Stock | 现货 >95% |
化学结构式Chemical structure

结构式由公开数据库渲染,仅供参考,以厂家图谱为准Structure rendered from public databases — indicative only
需要报价或 COA?Need a quote or COA?
直接联系销售顾问卢振明,附上本品 CAS 号即可(电话/微信/邮箱见页脚)。Contact our sales engineer Kaka Lu with this CAS number — phone, WeChat and e-mail are in the footer.
提交在线询价Submit enquiry产品介绍Product description
本产品为药物杂质对照品鲁拉西酮杂质35(Lurasidone Impurity 35,CAS 1373868-14-4),分子式 C28H34N4O3S,分子量 506.66。纯度 >95%。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
在现行药典和法规框架下,药物杂质对照品的合规要求中明确涉及对包括鲁拉西酮杂质35在内的目标物的控制。 分子式为 C28H34N4O3S 的鲁拉西酮杂质35(CAS 1373868-14-4),作为药物杂质分析中常用的定量对照标准品,为行业实验室广泛采纳。 从化学结构特征来看,鲁拉西酮杂质35的分子骨架中包含甾体骨架,酰胺类,含砜基,含羟基,含醚键。该化合物的不饱和度为14.0,表明结构中存在约14个环或双键等价单元。分子量为506.66 g/mol,属于较高分子量化合物。由于结构中存在共轭发色团,该化合物在200-400 nm区间具有显著的紫外吸收,便于HPLC-UV检测。 本品满足ISO 17034:2016和ISO Guide 35对认证标准物质的要求,适用于通过ISO/IEC 17025认可的GMP质量控制实验室。 每批次鲁拉西酮杂质35均采用质量平衡法结合定量NMR(qNMR)进行纯度定值,提供包含扩展不确定度(k=2)的COA证书,确保分析结果的计量溯源性。 在质量保证方面,鲁拉西酮杂质35的生产和定值严格遵循ISO 17034:2
Lurasidone Impurity 35 (CAS 1373868-14-4) is supplied by CATO as impurity reference standards for analytical and quality-control use.
Molecular formula C28H34N4O3S, molecular weight 506.7 g/mol. Supplied typically at >95% purity and normally held in stock. Each lot is accompanied by purity data and, where applicable, structural confirmation data; a certificate of analysis (COA) is available on request.
Lurasidone Impurity 35 is intended for use as a calibration standard, system suitability reference or impurity marker in quantitative analysis by HPLC, GC, LC-MS/MS or GC-MS.
Full technical description and application notes are available in the Chinese datasheet. Please contact our sales engineer for a translated summary.
应用场景Application notes
鲁拉西酮杂质35(Lurasidone Impurity 35,CAS 1373868-14-4)的标准化应用场景涵盖药品质量控制和药物分析等多个专业技术领域。 推荐应用流程: 1. 样品前处理 — 依据原料药或制剂特性,选择适当的提取和净化方法; 2. 色谱条件建立 — 以鲁拉西酮杂质35(纯度>95%)配制系统适用性溶液,验证分离度(Rs)不小于1.5; 3. 系统适用性 — 连续进样6针计算峰面积RSD,应不大于2.0%; 4. 定量流程 — 外标法或校正因子法计算目标杂质含量,结果以%面积报告。 质量控制要求:每批分析应包含空白、质控和双重分析(du
Typical applications include: external-standard calibration curves; system suitability testing (resolution ≥ 1.5, peak-area RSD ≤ 2.0% over six injections); identification and quantification of related substances; forced-degradation and stability-indicating studies; and method validation for impurity limits. Prepare working solutions freshly for low-concentration use (<10 µg/mL) and protect from light.
Detailed recommended procedures are provided in the Chinese datasheet.
理化性质Physical & Chemical Properties
| 外观形态Appearance | 淡黄色至黄色结晶性粉末。(含硫化合物特征性气味) |
| 储存条件Storage | 阴凉处(≤25°C)保存,避光,密封防潮 |
| 溶解性参考Solubility | 可溶于DMSO、DMF、甲醇 |
| 稳定性Stability | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封 |
| 化合物类型Compound Type | 药物杂质对照品 |
| 子类Sub-class | EP药典杂质 |
| 不饱和度(DBE)Unsaturation (DBE) | 14.0 |
| UV特征UV Absorption | 有紫外吸收 |
| 结构特征Structural Features | 含芳环 |
| CAS登记年份(估)CAS Reg. Year (est.) | 1991年 |
| 含氮原子数Nitrogen Atoms | 4 |
| 含硫原子数含硫原子数 | 1 |
性质数据摘录自厂家技术资料,实际数值以随货 COA 与书面确认为准。Quoted from the manufacturer's datasheet; the COA and our written confirmation prevail.
结构标识Identifiers
标识数据来自 PubChem 公开数据库的 CAS 匹配结果,仅用于结构交叉核对,以厂家图谱为准。Identifiers matched from the public PubChem database by CAS number for cross-checking only; the manufacturer's spectral data prevails.
杂质信息与使用建议Impurity information and usage notes
以下为通行实践提示,供方法开发与采购决策参考。General practice notes to support method development and purchasing decisions.
标准品建议 −20 ℃ 避光、干燥、密封保存;配制成溶液后现配现用,并在记录中注明开瓶日期与所用溶剂。Store at −20 °C, protected from light and moisture, in a well-sealed container. Prepare solutions fresh and record the opening date and solvent used.
随货提供 COA 及 HPLC、MS、NMR 等多维度定值数据;可按批索取图谱原始文件。The COA is supplied with multi-dimensional value-assignment data (HPLC, MS, NMR); raw spectra are available per lot on request.
按名称归类为「杂质对照品」。具体归属请以你们的工艺与降解研究结论为准。Classified by name as “Impurity standard”. Final assignment should follow your own process and degradation studies.
询价 / 索取 COARequest a quote / COA
提交后由销售顾问 卢振明 直接对接,通常 1 个工作日内回复价格、纯度、规格与货期。Your enquiry goes directly to our sales engineer Kaka Lu, who normally replies with price, purity, pack size and lead time within one business day.
同品种其他杂质Other impurities of this drug substance
查看「盐酸鲁拉西酮」全部杂质 →View all Lurasidone Hydrochloride impurities →